You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The era of therapeutic nihilism in dementia has ended, with the emergence of agents for symptomatic treatment, those that delay the course of the disease or prevent the onset of dementia, and new methods to manage symptoms. With the expansion of therapies, there is a clear danger of being overwhelmed by the volume of data. This book is designed to collect this information, distil what is relevant and reliable, and present it in a format that is useful to clinicians who manage and treat people with dementia. The book is designed to bring together the latest, best and practical evidence on all aspects of management, from diagnosis and therapy to social and ethical considerations. The editors are all dynamic clinicians involved in the care of patients with dementia and the evaluation of therapies. Two of the editors are the leaders of the Cochrane Collaboration for the examination of therapies for dementia. There are no other books that take such a practical and problem-oriented or approach to the diagnosis and management of dementia. Furthermore none but this can be described as truely evidence-based.
We live in an aging world. Illnesses that are prevalent and cause significant morbidity and mortality in older people will consume an increasing share of health care resources. One such illness is depression. This illness has a particularly devastating impact in the elderly because it is often undiagnosed or inadequately treated. Depression not only has a profound impact on quality of life but it is associated with an increased risk of mortality from suicide and vascular disease. In fact for every medical illness studied, e.g. heart disease, diabetes, cancer, individuals who are depressed have a worse prognosis. Research has illuminated the physiological and behavioral effects of depression ...
This is the most comprehensive update of basic and clinical information available on mental, addictive and various neurological disorders. Virtually every basic and clinical scientific methodology that is relevant to our understanding and management of brain-related diseases is included in this volume. Readers will find up-to-the-minute studies in functional brain imaging, including MRI and EEG/ERP mapping, the latest application of molecular biology and genetics to solve clinical problems, as well as recent findings on schizophrenia, Alzheimer's disease, drug addiction and alcoholism, suicide and mood disorders. A unique feature of this publication are the nine chapters which examine chroni...
In today's time-pressured managed care environment, it is important for clinicians to quickly identify the nature of a patient's problem and initiate treatment. With thousands of psychological instruments available, this can often be difficult. This book offers a form of psychological assessment "triage." It eliminates the guesswork and helps psychologists quickly select, administer, and interpret psychological tests.
The number of psychiatric researchers does not seem to be keeping pace with the needs and opportunities that exist in brain and behavioral medicine. An Institute of Medicine committee conducted a broad review of the state of patient-oriented research training in the context of the psychiatry residency and considered the obstacles to such training and strategies for overcoming those obstacles. Careful consideration was given to the demands of clinical training. The committee concluded that barriers to research training span three categories: regulatory, institutional, and personal factors. Recommendations to address these issues are presented in the committee's report, including calling for r...
Thoroughly updated for its Fourth Edition, this volume is the most authoritative clinical reference on the pharmacologic treatment of psychiatric disorders in elderly patients. This edition provides complete information on new psychotropic drugs, new uses for established drugs, and clinically relevant advances in the neurosciences. Four new chapters cover genes, pharmacokinetics, and their impact on prescribing; new cognitive-enhancing strategies and drugs; late-life depression and physical illness; and depression and cardiac disease in late life. The book offers detailed guidelines—including drug names, dosages, and prescribing recommendations—for pharmacologic treatment of specific disorders. Chapters include clinical vignettes and tables presenting current clinical trial data. Appendices provide succinct information on prescribing and drug interactions.
None
"The Oxford Handbook of Geropsychology provides students and experienced clinicians and clinical researchers alike with a comprehensive and contemporary overview of developments in the field of geropsychology. Informed by an international perspective, the introductory section covers demographics, meta-analyses in geropsychology, social capital and gender, cognitive development, and ageing. Sections on assessment and formulation include chapters on interviewing older people, psychological assessment strategies, capacity and suicidal ideation, and understanding long term care environments. Psychological distress and their causes are reviewed with chapters focusing upon late-life depression and...
Part of the 'Oxford Psychiatry Library' series, this concise pocket book provides an accessible account of how depression in older people presents, why it is important, and what treatments help.
None